Aleafia Health (DB:ARAH) - Cours de l'action, nouvelles et analyse

ARAH Aperçu des actions

Aleafia Health Inc., together with its subsidiaries, operates as cannabis health and wellness company in Canada, Europe, and Australia. Plus de détails

ARAH analyse fondamentale
Score flocon de neige
Évaluation	2/6
Croissance future	0/6
Performances passées	0/6
Santé financière	0/6
Dividendes	0/6

Analyse des risques

Les revenus ont diminué de 30% par an au cours des 5 dernières années

N'a pas de capitalisation boursière significative ( €8M )

Capitaux propres négatifs

Les actions sont très illiquides

+ 1 plus de risques

Aleafia Health Inc. Concurrents

Biofrontera

XTRA:B8FK

€15.8m

SynBiotic

DUSE:SBX

€27.9m

Cantourage Group

XTRA:HIGH

€57.9m

Redx Pharma

DB:0RX

€65.0m

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour Aleafia Health
Historique des cours de bourse
Prix actuel de l'action	CA$0.015
Plus haut sur 52 semaines	CA$0.079
Plus bas sur 52 semaines	CA$0.0005
Bêta	1.73
1Variation sur 1 mois	0%
Variation sur 3 mois	3,000.00%
Variation sur 1 an	-50.79%
3Variation sur 3 ans	-94.60%
Variation sur 5 ans	-97.67%
Évolution depuis l'introduction en bourse	-96.70%

Nouvelles et mises à jour récentes

Recent updates

Rendement pour les actionnaires

	ARAH	DE Pharmaceuticals	DE Marché
7D	0%	-0.3%	0.8%
1Y	-50.8%	-18.3%	8.6%

Rendement vs Industrie: ARAH a sous-performé le secteur German Pharmaceuticals qui a rapporté -18.3 % au cours de l'année écoulée.

Rendement vs marché: ARAH a sous-performé le marché German qui a rapporté 8.6 % au cours de l'année écoulée.

Volatilité des prix

Is ARAH's price volatile compared to industry and market?
ARAH volatility
ARAH Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	6.9%
Market Average Movement	4.8%
10% most volatile stocks in DE Market	10.9%
10% least volatile stocks in DE Market	2.4%

Cours de l'action stable: Le cours de l'action de ARAH a été volatil au cours des 3 derniers mois.

Volatilité au fil du temps: Données insuffisantes pour déterminer l'évolution de la volatilité de ARAH au cours de l'année écoulée.

À propos de l'entreprise

Fondée	Salariés	PDG	Site web
n/a	158	Tricia Symmes	www.aleafiahealth.com

Aleafia Health Inc. Résumé des fondamentaux

Comment les bénéfices et les revenus de Aleafia Health se comparent-ils à sa capitalisation boursière ?
ARAH statistiques fondamentales
Capitalisation boursière	€5.48m
Bénéfices(TTM)	-€23.53m
Recettes(TTM)	€29.13m

0.2x

Ratio P/S

-0.2x

Ratio P/E

Le site ARAH est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
ARAH compte de résultat (TTM)
Recettes	CA$42.85m
Coût des recettes	CA$36.85m
Marge brute	CA$6.00m
Autres dépenses	CA$40.61m
Les revenus	-CA$34.61m

Derniers bénéfices déclarés

Mar 31, 2023

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)	-0.086
Marge brute	14.00%
Marge bénéficiaire nette	-80.77%
Ratio dettes/capitaux propres	-499.1%

Quelles ont été les performances à long terme de ARAH?

Voir les performances historiques et les comparaisons

ARAH Aperçu des actions

Analyse des risques

Aleafia Health Inc. Concurrents

XTRA:B8FK

€15.8m

DUSE:SBX

€27.9m

XTRA:HIGH

€57.9m

DB:0RX

€65.0m

Historique des prix et performances

Nouvelles et mises à jour récentes

Red White & Bloom Brands Inc. (CNSX:RWB) completed the acquisition of One Plant (Retail) Corp. and Certain assets of Aleafia Health Inc. for $31.7 million.

Red White & Bloom Brands Inc. (CNSX:RWB) acquired Certain assets of Aleafia Health Inc. for $31.6677 million.

Red White & Bloom Brands Inc. (CNSX:RWB) entered into a stalking horse asset purchase agreement to acquire Certain assets of Aleafia Health Inc.

Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process

New major risk - Financial position

Full year 2023 earnings released: CA$0.09 loss per share (vs CA$0.42 loss in FY 2022)

Recent updates

Red White & Bloom Brands Inc. (CNSX:RWB) completed the acquisition of One Plant (Retail) Corp. and Certain assets of Aleafia Health Inc. for $31.7 million.

Red White & Bloom Brands Inc. (CNSX:RWB) acquired Certain assets of Aleafia Health Inc. for $31.6677 million.

Red White & Bloom Brands Inc. (CNSX:RWB) entered into a stalking horse asset purchase agreement to acquire Certain assets of Aleafia Health Inc.

Aleafia Health Obtains Creditor Protection to Pursue Restructuring and Sale Process

New major risk - Financial position

Full year 2023 earnings released: CA$0.09 loss per share (vs CA$0.42 loss in FY 2022)

Red White & Bloom Brands Inc. (CNSX:RWB) entered into a binding letter agreement to acquire Aleafia Health Inc. (TSX:AH) from shareholders for CAD 74.98 million.

High number of new and inexperienced directors

Third quarter 2023 earnings released: CA$0.062 loss per share (vs CA$0.22 loss in 3Q 2022)

Aleafia Health Inc. to Report Q3, 2023 Results on Feb 08, 2023

Now 33% undervalued

Aleafia Health Inc. Announces Board Changes

Now 36% undervalued after recent price drop

High number of new and inexperienced directors

High number of new and inexperienced directors

Aleafia Health Inc. to Report Q2, 2023 Results on Nov 09, 2022

Aleafia Health Expands Sunday Market House of Brands with Coveted Lineup of Winter Product Launches

Aleafia Health Announces TSX Decision to Extend Delisting Review Period to November 29, 2022

Aleafia Health Inc. to Report Q2, 2022 Results on Aug 11, 2022

Aleafia Health Inc., Annual General Meeting, Sep 27, 2022

High number of new and inexperienced directors

Full year 2022 earnings released: CA$0.42 loss per share (vs CA$0.84 loss in FY 2021)

Aleafia Health Inc. Reaffirms Revenue Guidance for the Fiscal Year 2023

Aleafia Health Inc. announced that it has received CAD 5.6225 million in funding

High number of new and inexperienced directors

Aleafia Health Inc. announced that it expects to receive CAD 5.6225 million in funding

High number of new and inexperienced directors

Aleafia Health Inc. Reaffirms Earnings Guidance for the Fiscal Year 2022

Aleafia Health Inc. Announces Impairment of Property, Plant & Equipment for the Fourth Quarter Ended December 31, 2021

Full year 2021 earnings: EPS in line with expectations, revenues disappoint

Aleafia Health Inc. to Report Q4, 2021 Results on Feb 14, 2022

Aleafia Health Inc. Announces Executive Changes

Third quarter 2021 earnings released: CA$0.25 loss per share (vs CA$0.066 loss in 3Q 2020)

High number of new and inexperienced directors

Aleafia Health Launches Premium Cannabis Brand Nith & Grand

Aleafia Health Expands Bogart’s Kitchen Edibles Portfolio with Launch of Salted Caramel Pretzel Bites

Aleafia Health Inc. Announces It Has Largely Completed Planting Across 86 Acres At Its Outdoor Cultivation Facility in Port Perry, Ont

Aleafia Health Inc. Expands Trailblazing Wellness Brand Noon & Night with Launch of Freshly Minted Roll-On

CFO & Corporate Secretary Benjamin Ferdinand has left the company

Aleafia Health Inc.'s Everyday Cannabis Brand Divvy Launches Large Format Dried Flower Portfolio

First quarter 2021 earnings released: CA$0.036 loss per share (vs CA$0.022 loss in 1Q 2020)

Aleafia Health Inc. Secures Health Canada Research Licence

Full year 2020 earnings released: CA$0.85 loss per share (vs CA$0.18 loss in FY 2019)

Aleafia Health Expands Adult-Use Presence with Entrance in Saskatchewan, New Provincial Market

Aleafia Health Inc. has completed a Composite Units Offering in the amount of CAD 19.92 million.

Aleafia Health Inc. Launches THC Soft Chews Under its Edibles Brand Bogart’s Kitchen

Aleafia Health Inc. to Report Q4, 2020 Results on Mar 25, 2021

Aleafia Health Secures Licence for Toronto Distribution Centre, Expanding Supply Chain and Ecommerce Opportunity

Aleafia Health Inc. Launches Sunday Market House of Brands

New 90-day high: €0.59

Aleafia Health Inc. Announces Directorship Appointments

Aleafia Health Announces Resignation Rhonda Lawson as Director

Unifor and Aleafia Health Enter Exclusive Agreement to Support Medical Cannabis Coverage for Members

Aleafia Health Inc. Enters Definitive Supply Agreement with Apipharm

Unifor and Aleafia Health Inc. Partner on Groundbreaking Medical Cannabis Coverage

New 90-day high: €0.38

Aleafia Health Enters into Supply Agreement with Robes Cannabis Inc

Aleafia Health Launches High Potency CBD 50 Cannabis Oil

Aleafia Health Inc. Launches Kin Slips® Rapid Onset Cannabis-Infused Sublingual Strips

Third quarter 2020 earnings released: CA$0.066 loss per share